Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03148743

FMT in Gut aGVHD Treated

With the stem cell transplanting increasing, patients which effected with gut GVHD were also increased. To evaluation the safety and efficacy of FMT for gut GVHD,patients with gut GVHD were recruited.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Acute-graft-versus-host Disease

Age range

10 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • gut GVHD

Exclusion criteria

  • Age>60; or Age<10

Treatment and study plan

Fecal microbiota

Biological

fecal microbiota transplantation

Primary outcomes

  1. times of stool

    Time frame: 24hours,48hours,72hours, 96hours,fifth day,sixth day, a week

    Change from stool times in a week

Secondary outcomes

  1. volume in milliliter of stool

    Time frame: 24hours,48hours,72hours, 96hours,fifth day,sixth day, a week

    Change from stool volume in a week

Study contacts

Contact information is provided by the study sponsor or research team.

xiaofei qi

CONTACT

[email protected]

1-86-512-67780410

Sponsors and collaborators

Lead sponsor

The First Affiliated Hospital of Soochow University

Other

Registry information

Official study title

Department of Hematology of First Affiliated Hospital of Soochow University

Important dates

Study start
2017
Primary completion
2028
Study completion
2029
First posted
May 11, 2017
Registry last updated
Jun 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.